Scott Pesiridis PhD

GlaxoSmithKline

Appearances

Industry Panel Discussion
Date
September 23, 2020
Co-Chairs
Roger Greenberg, MD, PhD
University of Pennsylvania
Alan D. D'Andrea, MD
Dana-Farber Cancer Institute
Speakers
Katya Marjon, PhD
Agios Pharmaceuticals
Josep V. Forment, PhD
AstraZeneca
Scott Pesiridis, PhD
GlaxoSmithKline
Robert T. Abraham, PhD
Vividion Therapeutics
Cory Johannessen
Novartis
Therapeutic Modulation of the STING Pathway
Date
April 12, 2021
Speaker
Scott Pesiridis, PhD
GlaxoSmithKline
Career Roundtable
Date
April 12, 2021
Panelists
Kate A. Fitzgerald, PhD
University of Massachusetts Medical School
Barbara Rehermann, MD
NIDDK, National Institutes of Health
Scott Pesiridis, PhD
GlaxoSmithKline

Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.